drugset / Trial / NCT02144259

The Impact of Contraception on Postpartum Weight Loss

NCT02144259

Completed 100 enrolled University of Pennsylvania
RandomizedParallel-groupOpen-labelBasic science

Summary

This is a prospective mixed methods study to assess weight changes in women randomized to receive Implanon ® or Depo Provera® (DMPA) immediately postpartum compared to women who choose non-hormonal contraception or no contraception immediately postpartum. After enrollment, subjects return for a visit at 3, 6 and 12 months postpartum to be asked a series of questions, take a pregnancy test, and be weighed. Total length of participation for each subject is 1 year or until pregnancy.

Timeline

Start
2011-04
Primary completion
2012-10
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Etonogestrel Unknown 68 mg Other
Comparator medroxyprogesterone acetate Other / unclassified 150 mg Intramuscular

Indications

No indication recorded.